Skip to navigation Skip to content



New Guideline on Vaccines for People with MS

August 29, 2019

The American Academy of Neurology has released a new set of guidelines on the use and safety of vaccines in people with MS. The guidelines are based on a review of available scientific literature.
Key findings are as follows:
  • There is no definite evidence that vaccines increase the likelihood that a person will develop MS.
  • If you have MS, it’s appropriate for you to receive vaccines according to standard vaccine guidelines, including annual flu vaccines. Special considerations do exist, and are listed here.
  • Some vaccinations may not work as well in people taking certain disease-modifying therapies. If you use an MS disease-modifying therapy, talk with your MS healthcare provider about which vaccines are safe for you to receive and when it is safe to receive them.  (Read specific information on various therapies here.)
  • People  who are experiencing MS relapses should consider waiting until the relapse has passed before receiving a vaccine.
More information on vaccine safety is available here.
Decisions about the potential benefits and risks of any given immunization should be made in consultation with your healthcare providers, including your family physician and neurologist.
Read More
Read a summary of the new guidelines for patients
Read a summary for healthcare professionals

About Multiple Sclerosis

Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.


© 2022 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.